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Abstract
Objectives The structured digital dosing guidelines of the web-based Dutch Paediatric Formulary provided the opportunity 
to develop an integrated paediatric dose calculator. In a simulated setting, we tested the ability of this calculator to reduce 
calculation errors.
Methods Volunteer healthcare professionals were allocated to one of two groups, manual calculation versus the use of the 
dose calculator. Professionals in both groups were given access to a web-based questionnaire with 14 patient cases for which 
doses had to be calculated. The effect of group allocation on the probability of making a calculation error was determined 
using generalized estimated equations (GEE) logistic regression analysis. The causes of all the erroneous calculations were 
evaluated.
Results Seventy-seven healthcare professionals completed the web-based questionnaire: thirty-seven were allocated to the 
manual group and 40 to the calculator group. Use of the dose calculator resulted in an estimated mean probability of a cal-
culation error of 24.4% (95% CI 16.3–34.8) versus 39.0% (95% CI 32.4–46.1) with use of manual calculation. The mean 
difference of probability of calculation error between groups was 14.6% (95% CI 3.1–26.2; p = 0.013). In a secondary analysis 
where calculation error was defined as a 10% or greater deviation from the correct answer, the corresponding figures were 
19.5% (95% CI 13–28.2) versus 26.5% (95% CI 21.6–32.1) with a mean difference of 7% between groups (95% CI 2.2–16.3; 
p = 0.137). Juxtaposition, typo/transcription errors and non-specified errors were more frequent as cause of error in the 
calculator group; exceeding the maximum dose and wrong correction for age were more frequent in the manual group. The 
percentage of tenfold errors was 3.1% in the manual group and 3.7% in the calculator group.
Conclusions Our study shows that the use of a dose calculator as an add-on to a web-based paediatric formulary can reduce 
calculation errors. Furthermore, it shows that technologies may introduce new errors through transcription errors and wrongly 
selecting parameters from drop-down lists. Therefore, dosing calculators should be developed and used with special attention 
for selection and transcription errors.
1 Introduction
Among all paediatric prescribing errors, dosing errors are 
the most common, accounting for 2.2–36.5% of all prescrib-
ing errors [1–7]. Incorrect dosing is thought to be caused by 
the complexity of paediatric prescribing, as nearly all drugs 
have varying dose recommendations based on the child’s 
age, weight or body surface area [8]. Furthermore, drugs are 
diluted and manipulated to meet the need for small doses. In 
addition, clear dosing guidance is lacking for off-label drugs 
[5–8]. Of all dosing errors, calculation errors are the most 
common in neonatal and paediatric patients. Davis et al. and 
Kirk et al. report error rates varying from 8.4 to 28.2% [4, 
9]. Studies by Rowe et al. and Glover and Sussmane confirm 
that healthcare professionals have difficulties calculating the 
correct dose [10, 11]. Kaushal et al. show that 34% of all 
potential adverse drug events (ADEs) in paediatric inpatients 
involve incorrect dosing [6]. Therefore, there is an urgent 
need to reduce the number of calculating errors.
The availability of digitized paediatric dosing guide-
lines of the Dutch Paediatric Formulary [12] provided the 
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opportunity to develop a website-integrated dose calculator 
that combines dosing recommendations of the formulary 
with patient variables. A manuscript describing the devel-
opment of the calculator has been accepted for publication 
[13]. In a simulated setting, we tested the ability of the cal-
culator to reduce calculation errors.
2  Methods
2.1  Study Setting
This performance study was designed as a non-randomized, 
comparative simulation trial comparing the odds ratios for 
calculation errors in a standardized calculation assessment 
in a control group versus an intervention group.
2.2  Participants
All users of the Dutch paediatric formulary were invited 
through the formulary’s homepage to voluntarily participate 
in a calculation assessment. Participants were categorized by 
their profession—physicians, pharmacists or other profes-
sionals (nurses/pharmacy technicians)—in order of date of 
registration.
Personal data other than age, profession and IP address 
were not collected. The simulation study was not subject to 
Institutional Review Board approval according to the Dutch 
Medical Research Involving Human Subjects Act (WMO).
2.3  Sample Size Calculation and Group Allocation
Although participants were not strictly randomly allocated 
to one of the groups, we applied equation 4 for cluster rand-
omized trials described by Hayes and Bennett [14] to calcu-
late the power of the study, in order to address the multiple 
dichotomous outcomes of each respondent. This calculation 
resulted in a minimum sample size of 34 per group to show a 
50% reduction in overall error rate with a power of 80% and 
a significance level of 0.05, using a coefficient of variation 
of 0.6 when each subject performed 23 calculations. Based 
on the study of Rowe et al. we estimated the a priori error 
rate at 10% [10].
Two hundred and thirty-eight users registered to partici-
pate. Numbers 1–25 of each profession group were allocated 
to the control group; numbers 26–50 of each profession 
group were allocated to the calculator group. Numbers from 
51 onwards of each group (88 out of 238) were excused. 
Anticipating a 50% non-response, we invited 75 participants 
per study group (25 physicians, 25 pharmacists and 25 other 
professionals) to achieve a minimal inclusion of 34 partici-
pants per study group.
2.4  Intervention
The control group was instructed to perform a calculation 
assessment with conventional tools (i.e. a pocket calcula-
tor) and the dosing recommendations as listed on the Dutch 
Paediatric Formulary website. The intervention group was 
instructed to perform the same calculation assessment using 
the website-integrated dose calculator of the Dutch Paedi-
atric Formulary.
2.5  Calculation Assessment
The calculation assessment consisted of 14 case descrip-
tions with either one or two calculations per case (23 cal-
culation items in total). The cases covered the paediatric 
age range from neonate to adolescent; the selected drugs 
were regularly used drugs and different calculation chal-
lenges were presented: dosing based on milligrams per 
kilogram, on milligram per square meter of body surface 
area, on International Units (IU) per kilogram, respecting 
the maximum dose and using weight of a premature neonate 
in grams instead of kilograms. The control group and inter-
vention group each completed the same assessment. The 
cases were presented in a random order. Participants were 
instructed to always use the lowest dose of a dose range and 
to provide the calculation result in the specified dose unit. 
Specific instructions on rounding were not provided. The 
calculation assessment was designed as an online question-
naire using the Survey Gizmo online platform. The survey 
could be completed at any place and time at the discretion 
of the respondent. To mimic daily practices with stressful 
circumstances and to prevent meticulous (re-)calculations, 
the time for the calculating tasks was limited to 2 min per 
case. If a calculation was not completed within 2 min, the 
participant was automatically directed to the next question. 
Participants in the calculator group were instructed to read 
the online instruction manual or watch the online instruc-
tion tutorial on the use of the calculator before starting the 
Key Points 
In a simulated setting, the use of a dose calculator inte-
grated with a web-based paediatric formulary reduced 
the estimated marginal mean probability of a calculation 
error from 39 to 24%. Paediatric healthcare professionals 
therefore may benefit from using this technology.
At the same time, digital solutions for dose calculation 
should be used with due caution as they may introduce 
risks as well. Special attention is needed for correct 
selection of parameters and transferring the calculation 
results to other information systems.
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assessment. Participants in both groups were advised to 
open two different web browsers for the purpose of com-
pleting the assessment in Survey Gizmo and simultaneously 
consulting the Paediatric Formulary website. Participants 
were informed that the Survey Gizmo assessment could not 
be interrupted and completed afterwards. Multiple comple-
tions were identified by tracking of the IP address. To get 
accustomed to the procedure, the assessment started with 
a dummy question.
The control group completed the assessment prior to the 
online launch of the calculator (May–June 2015). The inter-
vention group completed the assessment after the launch 
of the calculator on September 7, 2015 (September 25, 
2015–February 04, 2016).
2.6  Data Analysis and Statistics
Survey results were included in the data analyses if six cal-
culation items or more had been completed. Of duplicate IP 
addresses, the survey with the highest number of completed 
calculation items was included in the analysis.
The primary outcome parameter was a dichotomous vari-
able indicating correct or erroneous calculation outcome. 
An erroneous calculation was defined as any deviation from 
the correct outcome plus or minus 0.05 units of dosing to 
account for minor rounding errors. Calculation outcomes 
not provided within the set time frame of 2 min qualified 
as missing data in the dataset. Any exceedance of the abso-
lute maximum dose was considered to be an erroneous 
calculation.
The definition of error for the primary outcome was 
very strict and did not reflect clinical practice, where a 10% 
deviation from the calculated dose is usually accepted and 
often even needed to enable administration of specific for-
mulations. Therefore, we performed a secondary analysis 
addressing the clinical relevance of the error. In this analysis, 
a calculation error was defined as a ≥ 10% deviation from the 
correct outcome.
The primary and secondary outcomes were analysed 
using generalized estimated equations (GEE) logistic regres-
sion analysis (i.e. a GEE model with a binomial error dis-
tribution and a logit link) to account for missing data and 
within-subject correlations. The independent variables in 
the GEE model were the calculation item (to account for 
the difficulty of the calculation), the group (manual or cal-
culator) and the interaction effect between the independent 
variables. The results are reported as (a) the estimated mar-
ginal mean probabilities of a calculation error and (b) the 
odds ratios (ORs) for the correct outcome obtained with the 
website-integrated calculator compared with that obtained 
with manual calculation. The estimated marginal mean prob-
abilities are the predicted probabilities of a calculation error 
adjusted for the effects of covariates and missing data. Due 
to the presence of an interaction effect, the ORs of group 
(calculator versus manual calculation) vary by calculation 
item.
Demographic data were analysed using percentages for 
categorical data (profession) and median and interquartile 
ranges for age. For each clinically relevant error, we tried 
to reproduce the erroneous calculation outcome by manual 
recalculation, thus retrieving the cause of the error. All 
causes for error were described and scored using percent-
ages for categorical data. Furthermore, the number of ten-
fold errors per group and per cause of error were evaluated. 
Statistical analysis on the cause of errors was not performed, 
due to the limited numbers per cause of error.
IBM SPSS version 21 was used for all analyses.
3  Results
3.1  Participants and Assessment
The participant groups were similar in age and profession 
(Table 1). Participants who did not report their profession 
were listed as profession ‘unknown’.
3.2  Reduction of Errors
The estimated mean difference in calculation error between 
the groups was 14.6% (95% CI 3.1–26.2; p = 0.013). In an 
analysis taking into account the clinical relevance of the 
error, the estimated mean difference decreased to 7% (95% 
CI 2.2–16.3; p = 0.137) (Table 2).
Due to the presence of an interaction effect, the ORs of 
the group (calculator versus manual calculation) varied by 
calculation item, thus representing the difficulty of the cal-
culation item.
The OR for correct outcome when using the website-
integrated dose calculator (instead of manual calculation) 
was statistically significant for eight items (items 1, 4, 8, 11, 
12, 18, 19 and 20) (Table 3). These items may be labelled 
‘difficult’ or error-prone calculations. Errors in items 1 and 
19 were related to exceeding the maximum dose above a 
pre-specified weight. Items 4, 8, 12, 18 and 19 all required 
a conversion of a dose from milligrams to millilitres. In 
item 11, many participants in the manual group (27/31) 
entered the single dose instead of the requested daily dose. 
When corrected for clinical relevance (Table 3), the use of 
the website-integrated dose calculator was associated with 
significant ORs for items 1, 8, 11, 17 and 19 only. Item 17 
(calculation of lactulose dose) shows a significant OR for 
correct calculation outcome in favour of manual calcula-
tion. Item 17 required participants to enter the outcome in 
milligrams while many participants in the website-integrated 
dose calculator group entered the outcome in grams, which 
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was the unit of dosing provided by the website-integrated 
dose calculator.
3.3  Qualitative Aspects of the Calculation Errors
Missing data comprised 12.9% of the calculations in the 
manual group and 18.4% of the calculations in the calculator 
group; these had been completed within the set time limit of 
2 min. Eleven respondents in the manual group completed 
all 23 calculation items versus nine respondents in the cal-
culator group (Table 4).
Causes of the erroneous calculations are presented in 
Table 5. Participants in both groups were likely to act by 
their clinical experience rather than instructions provided 
(‘incompliant with instructions’). For example, all respond-
ents were instructed to always select the lowest dose of a 
dose range. For the amoxicillin case (Table 3, items 3 and 
4), this would imply selection of 40 mg/kg/day out of the 
40–90 mg/kg/day range. However, respondents tended to 
calculate the dose of amoxicillin based on the regularly used 
dose of 50 mg/kg/day. For some erroneous calculations, 
we could not retrieve the causes by manual recalculation 
(‘Calculation error not specified’). In line with the finding 
of significant ORs for calculation items, the percentage that 
exceeded the maximum dose in the calculator group was 
lower than that of the manual group (Table 5). Table 5 also 
confirms the number of errors in the calculator group origi-
nating from the use of the incorrect unit of dosing (item 17). 
The website-integrated dose calculator requires participants 
to select the indication and route of administration from a 
pre-specified list. Wrong selection from these drop-down 
lists (also known as juxtaposition error), typo/transcription 
errors and non-specified errors are more frequent in the 
calculator group, while exceeding the maximum dose and 
wrong correction for age are more frequent in the manual 
group.
The percentage of tenfold errors in the calculator group 
was higher than that in the manual group (Table 4). Wrong 
transcription of the dosing unit—12 out of 19 errors in item 
17—and other transcription errors accounted for the 77% of 
tenfold errors in the calculator group (Table 6).
4  Discussion
Our data show that in a simulated setting the probability of 
a calculation error made by healthcare professionals is sig-
nificantly lower when they use a website-integrated dosing 
calculator instead of a pocket calculator. The ORs for correct 
calculation suggest that the use of the website-integrated 
dose calculator is most effective in preventing the absolute 
maximum daily dose being exceeded and in converting a 
dose in milligrams to a dose in millilitres. The qualitative 
analysis, however, did not show a large reduction in the per-
centage of milligram to millilitre conversion errors with the 
use of the website-integrated dosing calculator. Therefore, 
the conversion step may not be the primary cause of errone-
ous outcome in these calculation items. Instead, the error is 
likely to be caused by calculation steps prior to the milligram 
to millilitre conversion. Significant ORs, indicating difficulty 
of the calculations, were found for common drugs such as 
paracetamol, ferrous fumarate and ranitidine.
Published error rates for incorrect dosing in children vary 
from 11.3% of all prescription errors (n = 391) in paediatric 
inpatients [15] to 36.5% of all prescription errors (n = 192, 
concerning dosages that do not fall within 25% of the rec-
ommended dose) by junior doctors completing a prescribing 
competency assessment [4]. Our results for manual calcula-
tion suggest that percentages for incorrect dosing are more 
likely to be on the higher end of this range. The high error 
rate found in our study may be the consequence of the strict 
Table 1  Characteristics of the study population
IQR interquartile range
Group Manual calculation Calculator
Sample size, n 37 40
Age in years, median (IQR) 40 (16) 37 (14)
Profession, n (%)
 Physician 11 (30) 7 (17.5)
 Pharmacist 13 (35) 14 (35)
 Pharmacy technicians and nurses 7 (19) 9 (22)
 Unknown 6 (16) 10 (25)
Table 2  Estimated marginal mean probability of a calculation error per group
CI confidence interval
Definition of correct outcome Estimated marginal mean probability of a calculation error
Manual Calculator Estimated mean difference between groups
Absolute correct outcome 39.0% (95% CI 32.4–46.1) 24.4% (95% CI 16.3–34.8) 14.6% (95% CI 3.1–26.2; p = 0.013)
Clinically relevant error (10% or 
greater deviation from the correct 
answer)
26.5% (95% CI 21.6–32.1) 19.5% (95% CI 13–28.2) 7.0% (95% CI 2.2–16.3; p = 0.137)
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definition for erroneous calculation: any deviation exceed-
ing the correct outcome by 0.05 mg or 0.05 mL in both 
directions was considered an error. In clinical practice, a 
10% deviation from the calculated dose is usually accepted 
and often even needed to enable administration of specific 
formulations. In the secondary analysis, in which we took 
into account a 10% or greater deviation from the correct 
answer, the estimated mean probability decreased from 27 to 
19%, but the mean difference between groups was no longer 
significant (p = 0.137).
Although the probability of error rate was reduced from 
39 to 24% (and 27 to 19% when accepting 10% deviation) 
we are surprised to find a still high number of errors with 
the use of the website-integrated dose calculator. The error 
analyses reveal that the nature of errors is different in both 
groups. The website-integrated dose calculator provides a 
good technical solution to prevent the absolute maximum 
Table 4  Comparison of completion rate of calculations per group
IQR interquartile range
Group Manual Calculator
Total number of calculations performed 851 920
Number of correct calculations (clinically relevant) 518 (60.9%) 592 (64.3%)
Number of erroneous calculations (clinically relevant) 223 (26.2%) 159 (17.2%)
Number of tenfold errors (clinically relevant) 26 (3.1%) 34 (3.7%)
Number of missing calculations 110 (12.9%) 169 (18.4%)
Complete set of 23 calculation items 11 respondents 9 respondents
Number of calculations completed by respondents Median 22 items  
(min. 6, max. 23; IQR 3)
Median 21 items  
(min. 6, max. 23; IQR 4)
Table 5  Comparison of rate of types of errors per group
a Errors assumed to be caused by manual calculation instead of calculator-assisted calculation
Cause of error Manual Calculator
n (% of all erroneous  
calculations)
n (% of all erroneous 
calculations)
Exceeding maximum dose 60 (26.9) 8 (5)a
Incompliant with instructions 38 (17.0) 35 (22.0)
Calculation error not specified 34 (15.2) 39 (24.5)
Daily vs single dose mix-up 32 (14.4) 17 (10.7)
Selected dose from wrong age group 18 (8.1) 3 (1.9)
Error converting mg to mL 15 (6.7) 8 (5)
Rounding error 7 (3.1) 2 (1.3)
Incorrect transcription of unit of dosing 7 (3.1) 21 (13.2)
Typo/other transcription error 5 (2.1) 10 (6.3)
Selected dose from different indication (juxtaposition error) 4 (1.8) 10 (6.3)
Multiplied fixed dose by weight 2 (0.9) 2 (1.3)a
Birthweight versus current weight incorrect use 1 (0.5) 1 (0.6)a
Wrong route of administration (juxtaposition error) 0 (0) 3 (1.9)
Table 6  Comparison of rate of types of tenfold errors per group
a Errors assumed to be caused by manual calculation instead of calcu-
lator assisted calculation
Manual (n) Calculator (n)
Calculation error not specified 4 6
Exceeding max. dose 3 0
Incorrect transcription of unit of dosing 6 19
Typo/other transcription error 5 7
Incompliant to instructions 4 0
Error converting mg to mL 2 0
Multiplied fixed dose by weight 2 2a
Total 26 34
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dose being exceeded, incorrect milligram to millilitre con-
versions and wrong correction for age. At the same time, 
however, it introduces dosing errors based on juxtaposition 
(wrong selection from drop-down lists) and transcription, 
explaining the remaining error rate of 24% in the calculator 
group. These errors occur despite the programmed correc-
tive and preventive actions aimed at detection of erroneous 
selection of parameters and incorrect data entry. The high 
number of tenfold errors in the calculator group is explained 
by dosing unit errors and typo/transcription errors, together 
accounting for 77% of all tenfold errors. The tenfold dosing 
unit error is likely to be caused by the design of item 17 of 
the assessment, where the calculator provided the dose in 
grams, but the assessment required the outcome in milli-
grams. Differences in dosing units between systems and the 
need for transcription are likely to occur outside a simulation 
setting as well and may lead to major dosing errors.
The participants in the manual calculation group com-
pleted the survey before the website-integrated dose calcula-
tor was available on the Formulary’s website. Participants 
in the calculator group, however, might have used manual 
calculations instead of using the website-integrated dose cal-
culator. Four participants in the calculator group provided 
erroneous answers that by no means could have been gener-
ated with the website-integrated dose calculator considering 
the technical specifications (exceeding the maximum dose, 
multiplication of a fixed dose by weight, Table 5), even when 
instructions were not followed or incorrect parameters were 
selected. These four participants accounted for 52 of the 
159 calculation errors in the calculator group (33%), which 
may imply a greater favourable effect of using the website-
integrated dose than our results suggest.
Limitations of our assessment may consist of the devia-
tions from daily practice, the need to transcribe calculation 
results, the limited time in addition to the need to switch 
between multiple computer displays and the lack of super-
vision during the assessment. Furthermore, the written 
instructions on use of the calculator as well as the instruc-
tions for the assessment did not ensure the correct use of 
the calculator in the simulated assessment. The simulation 
setting therefore may have induced errors that are less likely 
to occur when using the calculator congruent to everyday 
clinical practice. From September 2015 to June 2017, a 
beta version was made available, and users were asked to 
use it cautiously and report any problems. Errors like the 
ones encountered in the study were not reported during 
this period. Still, underreporting is a recognized limitation 
of spontaneous reporting systems. Currently, the website-
integrated dose calculator is being used more than 30,000 
times a month. Having received several reports on suspected 
problems with the calculator, none of the reports identified a 
malfunction of the calculator. Therefore, we have confidence 
in the safety of the calculator in everyday practice.
Although computerized dose calculation is advocated as 
a major approach to prevent paediatric calculation errors 
[1, 16, 17], our study shows that this technology does not 
completely rule out dosing errors and in fact may generate 
new types of errors. Several other studies have identified 
similar unintended consequences of the implementation of 
health information technologies [18–22]. Healthcare profes-
sionals should, therefore, use these technologies with due 
caution. Nonetheless, our findings confirm the findings of 
Kirk et al., that the computerized dose calculation can help 
reduce calculation errors [9]. A print option for the calcula-
tion was installed to enable calculation checks. Connecting 
the website-integrated dose calculator to computerized phy-
sician order entry systems may further reduce calculation 
errors caused by transcription.
5  Conclusion
Our study shows that a dose calculator as an add-on to a 
web-based paediatric formulary can reduce calculation 
errors, but it may introduce new errors based on transcrip-
tion errors and the wrong selection of parameters from drop-
down lists. Therefore, dosing calculators should be devel-
oped and used with special attention paid to selection and 
transcription errors.
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